These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26712133)

  • 21. Colistin: new lessons on an old antibiotic.
    Yahav D; Farbman L; Leibovici L; Paul M
    Clin Microbiol Infect; 2012 Jan; 18(1):18-29. PubMed ID: 22168320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
    Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
    J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
    Falagas ME; Kasiakou SK
    Clin Infect Dis; 2005 May; 40(9):1333-41. PubMed ID: 15825037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane permeabilization of colistin toward pan-drug resistant Gram-negative isolates.
    Mohamed YF; Abou-Shleib HM; Khalil AM; El-Guink NM; El-Nakeeb MA
    Braz J Microbiol; 2016; 47(2):381-8. PubMed ID: 26991296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Update on Colistin in Clinical Healthcare Unit in the Kingdom of Saudi Arabia: A Narrative Review.
    Faidah H
    Curr Pharm Des; 2024; 30(36):2829-2834. PubMed ID: 39108120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extensively drug-resistant and pandrug-resistant Gram-negative bacteria in a tertiary-care hospital in Eastern India: A 4-year retrospective study.
    Mohapatra DP; Debata NK; Singh SK
    J Glob Antimicrob Resist; 2018 Dec; 15():246-249. PubMed ID: 30144638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valnemulin restores colistin sensitivity against multidrug-resistant gram-negative pathogens.
    Xu C; Zhang Y; Ma L; Zhang G; Li C; Zhang C; Li Y; Zeng X; Li Y; Dong N
    Commun Biol; 2024 Sep; 7(1):1122. PubMed ID: 39261709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance.
    Harris TL; Worthington RJ; Hittle LE; Zurawski DV; Ernst RK; Melander C
    ACS Chem Biol; 2014 Jan; 9(1):122-7. PubMed ID: 24131198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R; Estaitieh N; Mugharbil A; Jisr T; Abdallah DI; Ziade F; Sinno L; Ibrahim A
    Front Cell Infect Microbiol; 2015; 5():11. PubMed ID: 25729741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006-09).
    Gales AC; Jones RN; Sader HS
    J Antimicrob Chemother; 2011 Sep; 66(9):2070-4. PubMed ID: 21715434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous colistimethate for multidrug-resistant Gram-negative bacteria.
    Zavascki AP; Li J
    Lancet Infect Dis; 2008 Jul; 8(7):403-5. PubMed ID: 18582831
    [No Abstract]   [Full Text] [Related]  

  • 33. The in-vitro activity of colistin in gram-negative bacteria.
    Tan TY; Ng SY
    Singapore Med J; 2006 Jul; 47(7):621-4. PubMed ID: 16810437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiology and antimicrobial sensitivities of 536 multi-drug-resistant gram-negative bacilli isolated from patients treated on surgical wards.
    Maraki S; Mavros MN; Kofteridis DP; Samonis G; Falagas ME
    Surg Infect (Larchmt); 2012 Oct; 13(5):326-31. PubMed ID: 23013255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increasing burden of urinary tract infections due to intrinsic colistin-resistant bacteria in hospitals in Marseille, France.
    Abat C; Desboves G; Olaitan AO; Chaudet H; Roattino N; Fournier PE; Colson P; Raoult D; Rolain JM
    Int J Antimicrob Agents; 2015 Feb; 45(2):144-50. PubMed ID: 25497970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metallo-beta-lactamases in Gram-negative bacteria: introducing the era of pan-resistance?
    Maltezou HC
    Int J Antimicrob Agents; 2009 May; 33(5):405.e1-7. PubMed ID: 19095416
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colistin in critically ill patients.
    Boisson M; Gregoire N; Couet W; Mimoz O
    Minerva Anestesiol; 2013 Feb; 79(2):200-8. PubMed ID: 23241733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Confronting the threat of multidrug-resistant Gram-negative bacteria in critically ill patients.
    Cohen J
    J Antimicrob Chemother; 2013 Mar; 68(3):490-1. PubMed ID: 23152481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
    Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.